Guangdong Taiantang Pharmaceutical Co.,Ltd. Posted 853.6 Million Yuan Net Loss in 2022
Listen to the full version

Guangdong Taiantang Pharmaceutical Co.,Ltd. (广东太安堂药业股份有限公司) (002433.SZ) reported a net loss of 853.6 million yuan in 2022, widening 2.6% year-on-year.
Meanwhile, the company posted 724.8 million yuan in revenue, down 68% year-on-year.
At the end of the reporting period, it had 6.6 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 43.2%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR